These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5808462)

  • 1. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of intravenous tyramine and the cold pressor test to help elucidate a possible mechanism of action of a new isoquinoline compound shown to have antihypertensive properties in humans.
    Pocelinko R; Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):13-9. PubMed ID: 4896482
    [No Abstract]   [Full Text] [Related]  

  • 3. The investigation of adrenergic metabolism with 7H3-norepinephrine in psychiatric disorders. II. Temporal changes in the distribution of urinary tritiated metabolites in affective disorders.
    Rosenblatt S; Chanley JD; Leighton WP
    J Psychiatr Res; 1969 May; 6(4):321-33. PubMed ID: 4307103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical measurement of the function of the adrenal medulla and sympathetic system in the clinic].
    Jéquier E
    Schweiz Med Wochenschr; 1970 Mar; 100(12):532-6. PubMed ID: 4906883
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitro.
    Solomon HM; Ashley C; Spirt N; Abrams WB
    Clin Pharmacol Ther; 1969; 10(2):229-38. PubMed ID: 5775990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adrenergic amines and monoaminoxidases in essential arterial hypertension].
    Sicuteri F; Buffoni F; Michelacci S; Del Bene E
    Acta Vitaminol Enzymol; 1969; 23(1):45-63. PubMed ID: 4896867
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain.
    Rutledge CO
    J Pharmacol Exp Ther; 1970 Feb; 171(2):188-95. PubMed ID: 5413739
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic doses of cyproheptadine do not inhibit monoamine oxidase in man.
    Feldman JM; Roche J; Plonk JW
    J Clin Pharmacol; 1976; 16(2-3):106-9. PubMed ID: 943422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase in man by furazolidone.
    Pettinger WA; Soyangco FG; Oates JA
    Clin Pharmacol Ther; 1968; 9(4):442-7. PubMed ID: 5655478
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase in health and disease.
    Udupa A; Srinivasan S; Udupa KN
    Indian J Physiol Pharmacol; 1974; 18(2):73-85. PubMed ID: 4414711
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 13. High positive correlation between urinary free tyramine excretion rate and "whole body" norepinephrine turnover in depressed patients.
    Linnoila M; Karoum F; Potter WZ
    Biol Psychiatry; 1982 Sep; 17(9):1031-6. PubMed ID: 7138992
    [No Abstract]   [Full Text] [Related]  

  • 14. Occurrence and properties of monoamine oxidase in adrenergic neurons.
    Jarrott B
    J Neurochem; 1971 Jan; 18(1):7-16. PubMed ID: 5550080
    [No Abstract]   [Full Text] [Related]  

  • 15. Affective disorders and norepinephrine pharmacology.
    Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
    Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH; Epstein RS; Kopin IJ; Gordon EK
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of debrisoquin (Declinax) on adrenergic function and norepinephrine metabolism.
    Horst WD; Gattanell P
    Biochem Pharmacol; 1970 Jul; 19(7):2335-41. PubMed ID: 5520376
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of pressor sensitivity tests for detection of drugs with sympathetic nervous system activity.
    Leon AS; Abrams WB; Markowitz M; Meisner EC
    J Clin Pharmacol J New Drugs; 1969; 9(6):399-407. PubMed ID: 5260203
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of monoamine oxidase inhibitors and pyrogallol on the pressor response to adrenaline, noradrenaline, normetanephrine and tyramine in the rat.
    VANOV S
    Arch Int Pharmacodyn Ther; 1962 Jul; 138():51-61. PubMed ID: 13924773
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetaldehyde mediation in the mechanism of ethanol-induced changes in norepinephrine metabolism.
    Walsh MJ; Truitt EB; Davis VE
    Mol Pharmacol; 1970 Jul; 6(4):416-24. PubMed ID: 5429284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.